Virtus ETF Advisers’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.35M Buy
43,092
+1,550
+4% +$65.4K 0.52% 35
2026
Q1
$2.3M Sell
41,542
-7,034
-14% -$335K 1.07% 11
2025
Q4
$1.81M Hold
48,576
0.86% 16
2025
Q3
$1.97M Sell
48,576
-6,000
-11% -$198K 1.08% 11
2025
Q2
$1.39M Hold
54,576
0.85% 21
2025
Q1
$1.17M Buy
+54,576
New +$1.22M 0.76% 23

Other funds holding PAHC

Virtus ETF Advisers's PAHC Position: Q2 2026 in Review

Virtus ETF Advisers increased its Phibro Animal Health (PAHC) stake by 3.7% in Q2 2026, buying an estimated $65.4K and bringing the position to 43,092 shares worth $1.35M. The position accounts for 0.52% of the portfolio, ranked #35.

Virtus ETF Advisers first reported a position in PAHC in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.3M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Virtus ETF Advisers held 43,092 shares of Phibro Animal Health worth $1.35M as of Q2 2026.
  • Virtus ETF Advisers bought 1,550 Phibro Animal Health shares in Q2 2026, an estimated $65.4K.
  • Phibro Animal Health made up 0.52% of Virtus ETF Advisers's portfolio in Q2 2026, its #35 holding.
  • Virtus ETF Advisers first reported a position in Phibro Animal Health in Q1 2025 and has held it in 6 quarters since.
  • Virtus ETF Advisers's Phibro Animal Health position peaked at $2.3M in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.